Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | quinonoid dihydropteridine reductase | 0.0339 | 1 | 0.5 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | NAD(P) binding domain | 0.0324 | 0.951 | 1 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0019 | 0 | 0.5 |
Brugia malayi | dihydropteridine reductase-like | 0.0324 | 0.951 | 0.5 |
Toxoplasma gondii | 6,7-dihydropteridine reductase | 0.0324 | 0.951 | 0.5 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0339 | 1 | 0.5 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0339 | 1 | 0.5 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0019 | 0 | 0.5 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0339 | 1 | 0.5 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0019 | 0 | 0.5 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0019 | 0 | 0.5 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0339 | 1 | 0.5 |
Trypanosoma cruzi | quinonoid dihydropteridine reductase, putative | 0.0339 | 1 | 0.5 |
Schistosoma mansoni | dihydropteridine reductase | 0.0324 | 0.951 | 0.5 |
Chlamydia trachomatis | glutamine binding protein | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | dihydropteridine reductase-PC | 0.0324 | 0.951 | 0.5 |
Echinococcus granulosus | NADP binding domain | 0.0324 | 0.951 | 1 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0339 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.